David J. Livingston

10.2k total citations · 3 hit papers
54 papers, 6.7k citations indexed

About

David J. Livingston is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, David J. Livingston has authored 54 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Immunology. Recurrent topics in David J. Livingston's work include Signaling Pathways in Disease (12 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Peptidase Inhibition and Analysis (8 papers). David J. Livingston is often cited by papers focused on Signaling Pathways in Disease (12 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Peptidase Inhibition and Analysis (8 papers). David J. Livingston collaborates with scholars based in United States, Japan and France. David J. Livingston's co-authors include Matthew W. Harding, Michael Su, George Ku, Keisuke Kuida, Richard A. Flavell, Judith A. Lippke, Robert A. Aldape, W. Duane Brown, Yong Gu and Scott A. Raybuck and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

David J. Livingston

52 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme

1995 1.4k citations George Ku, Matthew W. Harding et al. Science profile →
Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme

1997 996 citations Yong Gu, George Ku et al. Science profile →
Structure and mechanism of interleukin-lβ converting enzyme

1994 705 citations Keith P. Wilson, John A. Thomson et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Livingston United States	32	4.6k	2.4k	820	672	564	54	6.7k
Gerrit Koopman Netherlands	27	3.0k 0.7×	2.9k 1.2×	868 1.1×	606 0.9×	516 0.9×	98	7.0k
Kenneth C. Parker United States	33	4.5k 1.0×	2.8k 1.1×	692 0.8×	667 1.0×	400 0.7×	65	7.9k
Atsushi Takahashi Japan	39	4.0k 0.9×	1.2k 0.5×	1.1k 1.3×	540 0.8×	578 1.0×	215	6.5k
Artin Mahboubi United States	18	4.3k 0.9×	1.9k 0.8×	1.2k 1.4×	425 0.6×	555 1.0×	21	6.3k
Matthew W. Harding United States	30	6.0k 1.3×	2.9k 1.2×	2.0k 2.4×	586 0.9×	419 0.7×	54	7.9k
P A Campbell United States	29	3.1k 0.7×	2.4k 1.0×	467 0.6×	407 0.6×	231 0.4×	54	6.0k
Nigel J. Waterhouse Australia	41	4.8k 1.1×	1.7k 0.7×	1.2k 1.4×	1.1k 1.6×	627 1.1×	76	7.5k
Christoph Borner Germany	50	6.1k 1.3×	1.6k 0.7×	1.3k 1.6×	1.2k 1.8×	959 1.7×	119	8.8k
Jakob Troppmair Austria	50	4.4k 1.0×	973 0.4×	1.0k 1.2×	547 0.8×	568 1.0×	157	7.9k
Paul H. Naccache Canada	56	4.2k 0.9×	3.7k 1.5×	798 1.0×	295 0.4×	851 1.5×	168	8.1k

Countries citing papers authored by David J. Livingston

Since Specialization

Citations

This map shows the geographic impact of David J. Livingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Livingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Livingston more than expected).

Fields of papers citing papers by David J. Livingston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Livingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Livingston. The network helps show where David J. Livingston may publish in the future.

Co-authorship network of co-authors of David J. Livingston

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Livingston. A scholar is included among the top collaborators of David J. Livingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Livingston. David J. Livingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chiang, Jason, et al.. (2023). Pediatric diencephalic tumors: a constellation of entities and management modalities. Frontiers in Oncology. 13. 1180267–1180267.

Futer, Olga, Michael D. Sintchak, Paul R. Caron, et al.. (2002). A mutational analysis of the active site of human type II inosine 5′-monophosphate dehydrogenase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1594(1). 27–39. 20 indexed citations

Fantuzzi, Giamila, Adrian Puren, Matthew W. Harding, David J. Livingston, & Charles A. Dinarello. (1998). Interleukin-18 Regulation of Interferon γ Production and Cell Proliferation as Shown in Interleukin-1β–Converting Enzyme (Caspase-1)-Deficient Mice. Blood. 91(6). 2118–2125. 15 indexed citations

Cameron, Andrew M., Frederick C. Nucifora, Eric T. Fung, et al.. (1997). FKBP12 Binds the Inositol 1,4,5-Trisphosphate Receptor at Leucine-Proline (1400–1401) and Anchors Calcineurin to this FK506-like Domain. Journal of Biological Chemistry. 272(44). 27582–27588. 184 indexed citations

Glaccum, Moira, Kim L. Stocking, K Charrier, et al.. (1997). Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. The Journal of Immunology. 159(7). 3364–3371. 324 indexed citations

Ku, George, et al.. (1996). INTERLEUKIN-1β CONVERTING ENZYME INHIBITION BLOCKS PROGRESSION OF TYPE II COLLAGEN-INDUCED ARTHRITIS IN MICE. Cytokine. 8(5). 377–386. 90 indexed citations

DeCenzo, Maureen T., et al.. (1996). FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes. Protein Engineering Design and Selection. 9(2). 173–180. 70 indexed citations

Itoh, Susumu, Maureen T. DeCenzo, David J. Livingston, David A. Pearlman, & Manuel A. Navia. (1995). Conformation of FK506 in X-ray structures of its complexes with human recombinant FKBP12 mutants. Bioorganic & Medicinal Chemistry Letters. 5(17). 1983–1988. 25 indexed citations

Gu, Yong, et al.. (1995). Cleavage of Poly(ADP-ribose) Polymerase by Interleukin-1β Converting Enzyme and Its Homologs TX and Nedd-2. Journal of Biological Chemistry. 270(32). 18715–18718. 145 indexed citations

10.

Armistead, David M., Michael C. Badia, David D. Deininger, et al.. (1995). Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506. Acta Crystallographica Section D Biological Crystallography. 51(4). 522–528. 52 indexed citations

11.

Lepre, Christopher A., et al.. (1994). Solution Structure of FK506 Bound to the R42K, H87V Double Mutant of FKBP-12. Biochemistry. 33(46). 13571–13580. 10 indexed citations

12.

Wilson, Keith P., John A. Thomson, Eunice E. Kim, et al.. (1994). Structure and mechanism of interleukin-lβ converting enzyme. Nature. 370(6487). 270–275. 705 indexed citations breakdown →

13.

Connelly, Patrick R., Robert A. Aldape, Frank J. Bruzzese, et al.. (1994). Enthalpy of hydrogen bond formation in aprotein-ligand binding reaction.. Proceedings of the National Academy of Sciences. 91(5). 1964–1968. 111 indexed citations

14.

Markland, William, et al.. (1989). Structure–function analysis of tissue-type plasminogen activator by linker-insertion, point and deletion mutagenesis. Protein Engineering Design and Selection. 3(2). 117–125. 7 indexed citations

15.

Fox, Judith A., David J. Livingston, W H Orme-Johnson, & Christopher T. Walsh. (1987). 8-Hydroxy-5-deazaflavin-reducing hydrogenase from Methanobacterium thermoautotrophicum: 1. Purification and characterization. Biochemistry. 26(14). 4219–4227. 108 indexed citations

16.

Livingston, David J., et al.. (1984). Influence of heme orientation on oxygen affinity in native sperm whale myoglobin. Journal of the American Chemical Society. 106(10). 3025–3026. 34 indexed citations

17.

Livingston, David J., Gerd N. La Mar, & W. Duane Brown. (1983). Myoglobin Diffusion in Bovine Heart Muscle. Science. 220(4592). 71–73. 70 indexed citations

18.

Livingston, David J., et al.. (1983). A microcomputer‐based high‐speed data‐acquisitionsystem for a stopped‐flowspectrophotometer: PDP‐11 architectureinterfaced to a commercial instrument. Journal of Analytical Methods in Chemistry. 5(2). 83–88. 3 indexed citations

19.

Livingston, David J. & W. Duane Brown. (1981). The chemistry of myoglobin and its reactions. Food technology. 162 indexed citations

20.

Chabner, Bruce A. & David J. Livingston. (1970). A simple enzymic assay for pyridoxal phosphate. Analytical Biochemistry. 34(2). 413–423. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact